Oxford Nanopore Technologies

During a large-scale study of complex single-celled microbes, scientists made an unexpected discovery. Built into the genome of the microbes, they found the DNA of over 30,000 previously unknown viruses. This "hidden" DNA may allow the replication of complete and functional viruses in the host cell.

The ability to study transcript isoforms in detail could have a significant impact on our understanding of health and disease. However, most commonly, bulk sequencing is the selected method that only provides an average of the transcripts expressed across your sample of cells.

We will introduce the National Institutes of Health Center for Alzheimer’s and Related Dementias long-read sequencing initiative, which will generate a new genetic resource for Alzheimer’s and related dementias from thousands of human brain samples.

In this webinar, our expert speaker, Vanessa Porter, will present her research into identifying and classifying genomic perturbations arising from HPV integration.

A novel DNA preparation protocol enables labs to isolate high molecular weight DNA from a variety of plant species cost-effectively and rapidly, opening opportunities to improve the robustness of commercially valuable plants.

Serious infectious disease outbreaks have been an ever-present threat throughout human history and, driven by factors such as increasing globalization, population growth, urbanization and climate change, that threat is increasing.

Take your sequencing to the next level with the recently released PromethION 2 devices. They enable flexible, high-yield sequencing, in a compact, accessible design.

Over recent years, genomic sequencing of pathogens has emerged as a powerful tool to guide public health action by providing a deeper understanding of pathogen evolution, emerging variants and transmission dynamics. Oxford Nanopore Technologies offers an accessible, all-in-one sequencing platform that enables rapid, distributed and scalable genomic pathogen surveillance.

In this webinar, you will hear from leaders in the field of microbiology and infectious disease research, who will share their experiences in developing and implementing fast and accessible pathogen surveillance protocols with nanopore sequencing. The protocols presented in this webinar can be leveraged for targeted whole genome sequencing of different viral pathogens such as SARS-CoV-2 and monkeypox virus, as well as more broadly for the genomic characterization of known and novel viruses in an untargeted manner.

The genetics behind cancer are both diverse and complex, with many abnormalities causing, contributing, or indicating the disease. Using nanopore sequencing, scientists can resolve variants and epigenetic modifications across the entire genome, target large panels or single genes, and detect known and novel full-length transcripts – for the most comprehensive insight into cancer genomes.

Our major findings were that the neural network was able to accurately classify 11 out of 12 leukemia samples, with as little as 5 minutes of sequencing needed to accurately classify ALL.